Table 1 Principal characteristics of patients with probable or proven pulmonary aspergillosis
Mean age (SD): 64 ± 9 years Gender (n males): 18 M ARDS due to COVID-19, n = 21 Delay between admission and the diagnosis of aspergillosis: 6.5 ± 4.2 days Antifungal therapy: 6/6 - Isavuconazole, n = 5 - Voriconazole, n = 1 Alive: 4/6 patients (67%) |